Predictive models can tell an intensive care team that a patient is likely to deteriorate; they cannot say what to do about it. Prescriptive artificial intelligence is designed to close that gap. By combining causal machine learning, which estimates what a treatment would do for a specific patient, with reinforcement learning, which builds adaptive treatment policies over time, these systems aim to move beyond risk scores and toward personalized, actionable recommendations for decisions such as fluids, vasopressors, or ventilator settings.
The Shift from Prediction to Prescription in Critical Care AI
"Critical care requires rapid decisions from complex, evolving data," as a recent review of prescriptive AI tools in critical care puts it, and that combination is precisely why prediction alone falls short. A model that forecasts deterioration identifies risk, but it does not provide direct guidance for intervention; the bedside team still faces the same question of which therapy to start, adjust, or withhold.
Prescriptive systems are defined by their functional output rather than their underlying algorithms alone. Where predictive analytics flags probability, a prescriptive model recommends specific treatment strategies aimed at guiding therapy and optimizing patient outcomes, according to the same review. A 2023 comprehensive review of AI in critical illness, published in Frontiers in Medicine by Muhammad Saqib and colleagues, frames the same shift: AI can assist clinical decision-making in a "symbiotic fashion with care-givers," presenting recommendations in an interpretable, hierarchical manner through techniques such as reinforcement learning. The distinction matters clinically because the value of a deterioration score is realized only once someone acts on it, and the prescriptive layer is what proposes that action.





